Updated: Mar 8, 2022
Promethean BioPharma supports the work of Mind Medicine Australia and encourages their submissions to the Therapeutic Goods Administration in relation to the rescheduling of psilocybin and MDMA from Schedule 9 to Schedule 8.
For more information:
https://mindmedicineaustralia.org.au/
The Therapeutic Goods Administration (TGA) has relaxed requirements on Nicotine as an unregistered medicine by making 'Authorised Prescriber' status for doctors just a matter of filling a form on the
For thousands of years, novel medicines have been used by humanity and been manufactured by major pharmaceutical companies in the 20th Century. However, vested interests in the paper, cotton, pharmace
Promethean BioPharma Limited has finalised the acquisition of Tcann Pty Ltd setting the stage for the execution of it's growth strategy.